The regulatory environment for cannabis and cannabis-derived products continues to evolve.  With new DEA regulations and proposed CBD regulations from the FDA on the horizon, knowing how to analyze products for compliance is critical.  Please join Jennifer K. Mason and Sarah K. diFrancesca, partners at Dinsmore & Shohl LLP, as they discuss the following topics:

  • Labeling and packaging regulations -- Where do you get started? (15 minutes)
  • The intended use of a product -- Why does it matter? (10 minutes)
  • Claims related to the diagnosis, cure, treatment or mitigation of any disease -- When are they permissible? (10 minutes)
  • Structure/Function claims -- How might these impact your label and compliance? (10 minutes)
  • Labeling and packaging content requirements -- What are they and where do you find them?  (15 minutes)